Chronotherapy using corticosteroids for multiple sclerosis relapses (Q36227089)

12 August 2017

0 references

Chronotherapy using corticosteroids for multiple sclerosis relapses (English)

1 reference

12 August 2017

0 references

Lea Glass-Marmor

1

1 reference

12 August 2017

Tamar Paperna

series ordinal

2

1 reference

12 August 2017

Yaara Ben-Yosef

series ordinal

3

1 reference

12 August 2017

Ariel Miller

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

20 October 2006

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

12 August 2017

1 reference

12 August 2017

78

1 reference

12 August 2017

8

1 reference

12 August 2017

886-888

1 reference

Cancer chronotherapy: principles, applications, and perspectives

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

The tick-tock of the biological clock.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Biologic rhythms in the immune system

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

The chronotherapy of corticosteroids: practical application of chronobiologic findings to nursing

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance?

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2117717

Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

21 October 2018

1 reference

12 December 2020

A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Diurnal variations in vision and relations to circadian melatonin secretion in multiple sclerosis

1 reference

12 December 2020

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy

1 reference

12 December 2020

Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS

1 reference

12 December 2020

Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.2006.104000

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

17056624

1 reference